483
Gulf Coast Regional Blood CenterGulf Coast Regional Blood Center – FDA 483, Sep 14, 2022
Record Details
An FDA inspection of Gulf Coast Regional Blood Center in Houston, TX, revealed a significant issue regarding donor eligibility. The firm failed to properly defer a donor of blood and blood components, despite their own reference table indicating an indefinite deferral. This indicates a lapse in adherence to established donor screening protocols.
View Company Profile
ID · b1fea2b7-61ec-46d6-ac20-bacb31a3e38b
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.